Related Experiment Video
Updated: Feb 5, 2026

Development and Assessment of Intracellular Infection Models for Staphylococcus aureus
Published on: January 17, 2025
Considerations for Clinical Trials of Staphylococcus aureus Bloodstream Infection in Adults
Thomas L Holland1, Henry F Chambers2, Helen W Boucher3
1Department of Medicine, Duke University Medical Center, Durham, North Carolina.
Abstract:
Clinical trials for Staphylococcus aureus bloodstream infections (SAB) are broadly grouped into 2 categories: registrational trials intended to support regulatory approval of antibiotics for the treatment of SAB and strategy trials intended to inform clinicians on the best treatment options for SAB among existing antibiotics. Both types of SAB trials are urgently needed but have been limited by cost, complexity, and regulatory uncertainty. Here, we review key SAB trial design considerations for investigators, sponsors, and regulators.
Related Concept Videos
Clinical Trials
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview
Statistical Software for Data Analysis and Clinical Trials
Endocarditis II: Clinical Features of Infective Endocarditis
Design Consideration
The factor of safety is another key...
Trial and Error and Algorithm

